Immune evasion of Enterococcus faecalis by an extracellular gelatinase that cleaves C3 and iC3b

Journal of Immunology

Volumn 181, Issue 9, 2008, Pages 6328-6336

  Shin, Yong Park ^a   Yong, Pyo Shin ^a   Chong, Han Kim ^a   Ho, Jin Park ^a   Yeon, Sun Seong ^b   Byung, Sam Kim ^c   Sook, Jae Seo ^d   In, Hee Lee ^a  

^a Hoseo University   (South Korea)

^b Dankook University   (South Korea)

^c University of Ulsan   (South Korea)

^d Gyeongsang National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C3B; GELATINASE; OPSONIN; WATER;

ARTICLE; BLOODSTREAM INFECTION; CONTROLLED STUDY; ENTEROCOCCUS FAECALIS; ENZYME ACTIVITY; HUMAN; IMMUNE RESPONSE; NEUTROPHIL; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; REACTOR CASCADE; AMINO ACID SEQUENCE; ANIMAL; CHICKEN; COMPLEMENT ACTIVATION; COMPLEMENT ALTERNATIVE PATHWAY; DOG; DRUG ANTAGONISM; ENZYMOLOGY; EXTRACELLULAR FLUID; GRAM POSITIVE INFECTION; GUINEA PIG; HYDROLYSIS; IMMUNOLOGY; METABOLISM; MICROBIOLOGY; MOLECULAR GENETICS; MOUSE; PHYSIOLOGY; SERUM BACTERICIDAL ACTIVITY;

AMINO ACID SEQUENCE; ANIMALS; BLOOD BACTERICIDAL ACTIVITY; CHICKENS; COMPLEMENT ACTIVATION; COMPLEMENT C3; COMPLEMENT C3B; COMPLEMENT PATHWAY, ALTERNATIVE; DOGS; ENTEROCOCCUS FAECALIS; EXTRACELLULAR FLUID; GELATINASES; GRAM-POSITIVE BACTERIAL INFECTIONS; GUINEA PIGS; HUMANS; HYDROLYSIS; MICE; MOLECULAR SEQUENCE DATA; NEUTROPHILS; PHAGOCYTOSIS;

EID: 58749114776     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.181.9.6328     Document Type: Article

References (44)

1. Rooijakkers, S. H., M. Ruyken, A. Roos, M. R. Daha, J. S. Presanis, R. B. Sim, W. J. van Wamel, K. P. van Kessel, and J. A. van Strijp. 2005. Immune evasion by a staphylococcal complement inhibitor that acts on C3 convertases. Nat. Immunol. 6: 920-927.
2. Kozel, T. R. 1996. Activation of the complement system by pathogenic fungi. Clin. Microbiol. Rev. 9: 34-46. (Pubitemid 26035537)
3. Gasque, P. 2004. Complement: a unique innate immune sensor for danger signals. Mol. Immunol. 41: 1089-1098. (Pubitemid 39345390)
4. McRae, J. L., T. G. Duthy, K. M. Griggs, R. J. Ormsby, P. J. Cowan, B. A. Cromer, W. J. McKinstry, M. W. Parker, B. F. Murphy, and D. L. Gordon. 2005. Human factor H-related protein 5 has cofactor activity, inhibits C3 convertase activity, binds heparin and C-reactive protein, and associates with lipoprotein. J. Immunol. 174: 6250-6256.
5. van Lookeren Campagne, M., C. Wiesmann, and E. J. Brown. 2007. Macrophage complement receptors and pathogen clearance. Cell. Microbiol. 9: 2095-2102. (Pubitemid 47250283)
6. Nilsson, M., M. Weineisen, T. Andersson, L. Truedsson, and U. Sjöbring. 2005. Critical role for complement receptor 3 (CD11b/CD18), but not for Fc receptors, in killing of Streptococcus pyogenes by neutrophils in human immune serum. Eur. J. Immunol. 35: 1472-1481. (Pubitemid 40691429)
7. Mölkänen, T., J. Tyynelä, J. Helin, N. Kalkkinen, and P. Kuusela. 2002. Enhanced activation of bound plasminogen on Staphylococcus aureus by staphylokinase. FEBS Lett. 24: 72-78. (Pubitemid 34327634)
8. Zipfel, P. F., R. Würzner, and C. Skerka. 2007. Complement evasion of pathogens: common strategies are shared by diverse organisms. Mol. Immunol. 44: 3850-3857.
9. Silverman, G. J., C. S. Goodyear, and D. L. Siegel. 2005. On the mechanism of staphylococcal protein A immunomodulation. Transfusion 45: 274-280.
10. Schenkein, H. A., H. M. Fletcher, M. Bodnar, and F. L. Macrina. 1995. Increased opsonization of a prtH-defective mutant of Porphyromonas gingivalis W83 is caused by reduced degradation of complement-derived opsonins. J. Immunol. 15: 5331-5337.
11. Rooijakkers, S. H., M. Ruyken, J. van Roon, K. P. van Kessel, J. A. van Strijp, and W. J. van Wamel. 2006. Early expression of SCIN and CHIPS drives instant immune evasion by Staphylococcus aureus. Cell. Microbiol. 8: 1282-1293.
12. Rooijakkers, S. H., K. P. van Kessel, and J. A. van Strijp. 2005. Staphylococcal innate immune evasion. Trends Microbiol. 13: 596-601.
13. Lee, L. Y., X. Liang, M. Höök, and E. L. Brown. 2004. Identification and characterization of the C3 binding domain of the Staphylococcus aureus extracellular fibrinogen-binding protein (Efb). J. Biol. Chem. 279: 50710-50716. (Pubitemid 40017808)
14. Langley, R., B. Wines, N. Willoughby, I. Basu, T. Proft, and J. D. Fraser. 2005. The staphylococcal superantigen-like protein 7 binds IgA and complement C5 and inhibits IgA-Fc α RI binding and serum killing of bacteria. J. Immunol. 174: 2926-2933. (Pubitemid 40279711)
15. Fernie-King, B. A., D. J. Seilly, A. Davies, and P. J. Lachmann. 2002. Streptococcal inhibitor of complement inhibits two additional components of the mucosal innate immune system: secretory leukocyte proteinase inhibitor and lysozyme. Infect. Immun. 70: 4908-4916.
16. Dupont, H. 2007. The empiric treatment of nosocomial intra-abdominal infections. Int. J. Infect. Dis. 11: S1-S6. (Pubitemid 46977798)
17. Karchmer, A. W. 2000. Nosocomial bloodstream infections: organisms, risk factors, and implications. Clin. Infect. Dis. 31: S139-S143. (Pubitemid 32291121)
18. Kayaoglu, G., and D. Ørstavik. 2004. Virulence factors of Enterococcus faecalis: relationship to endodontic disease. Crit. Rev. Oral Biol. Med. 15: 308-320.
19. Park, S. Y., K. M. Kim, J. H. Lee, S. J. Seo, and I. H. Lee. 2007. Extracellular gelatinase of Enterococcus faecalis destroys a defense system in insect hemolymph and human serum. Infect. Immun. 75: 1861-1869.
20. Rakita, R. M., N. N. Vanek, K. Jacques-Palaz, M. Mee, M. M. Mariscalco, G. M. Dunny, M. Snuggs, W. B. Van Winkle, and S. I. Simon. 1999. Enterococcus faecalis bearing aggregation substance is resistant to killing by human neutrophils despite phagocytosis and neutrophil activation. Infect. Immun. 67: 6067-6075.
21. Shaked, H., Y. Carmeli, D. Schwartz, and Y. Siegman-Igra. 2006. Enterococcal bacteraemia: epidemiological, microbiological, clinical and prognostic characteristics, and the impact of high level gentamicin resistance. Scand. J. Infect. Dis. 38: 995-1000. (Pubitemid 44869270)
22. Tacconelli, E. 2006. New strategies to identify patients harbouring antibiotic-resistant bacteria at hospital admission. Clin. Microbiol. Infect. 12: 102-109.
23. Koch, S., M. Hufnagel, C. Theilacker, and J. Huebner. 2004. Enterococcal infections: host response, therapeutic, and prophylactic possibilities. Vaccine 22: 822-830. (Pubitemid 38177382)
24. Montravers, P., A. Andremont, L. Massias, and C. Carbon. 1994. Investigation of the potential role of Enterococcus faecalis in the pathophysiology of experimental peritonitis. J. Infect. Dis. 169: 821-830. (Pubitemid 24102116)
25. Mäkinen, P. L., D. B. Clewell, F. An, and K. K. Mäkinen. 1989. Purification and substrate specificity of a strongly hydrophobic extracellular metalloendopeptidase ("gelatinase") from Streptococcus faecalis (strain 0G1-10). J. Biol. Chem. 264: 3325-3334. (Pubitemid 19063387)
26. Singh, K. V., X. Qin, G. M. Weinstock, and B. E. Murray. 1998. Generation and testing of mutants of Enterococcus faecalis in a mouse peritonitis model. J. Infect. Dis. 178: 1416-1420. (Pubitemid 28523280)
27. Coque, T. M., J. E. Patterson, J. M. Steckelberg, and B. E. Murray. 1995. Incidence of hemolysin, gelatinase, and aggregation substance among enterococci isolated from patients with endocarditis and other infections and from feces of hospitalized and community-based persons. J. Infect. Dis. 171: 1223-1229.
28. Elsner, H. A., I. Sobottka, D. Mack, M. Claussen, R. Laufs, and R. Wirth. 2000. Virulence factors of Enterococcus faecalis and Enterococcus faecium blood culture isolates. Eur. J. Clin. Microbiol. Infect. Dis. 19: 39-42.
29. Kanemitsu, K., T. Nishino, H. Kunishima, N. Okamura, H. Takemura, H. Yamamoto, and M. Kaku. 2001. Quantitative determination of gelatinase activity among enterococci. J. Microbiol. Methods 47: 11-16. (Pubitemid 32885601)
30. Arciola, C. R., L. Baldassarri, D. Campoccia, R. Creti, V. Pirini, J. Huebner, and L. Montanaro. 2008. Strong biofilm production, antibiotic multi-resistance and high gelE expression in epidemic clones of Enterococcus faecalis from orthopaedic implant infections. Biomaterials 29: 580-586.
31. Mohamed, J. A., and B. E. Murray. 2006. Influence of the fsr locus on biofilm formation by Enterococcus faecalis lacking gelE. J. Med. Microbiol. 55: 1747-1750.
32. Zeng, J., F. Teng, and B. E. Murray. 2005. Gelatinase is important for translocation of Enterococcus faecalis across polarized human enterocyte-like T84 cells. Infect. Immun. 73: 1606-1612. (Pubitemid 40470748)
33. Rozanov, D. V., A. Y. Savinov, V. S. Golubkov, T. I. Postnova, A. Remacle, S. Tomlinson, and A. Y. Strongin. 2004. Cellular membrane type-1 matrix metalloproteinase (MT1-MMP) cleaves C3b, an essential component of the complement system. J. Biol. Chem. 279: 46551-46557. (Pubitemid 39518299)
34. Jean, D., J. Hermann, F. Rodrigues-Lima, M. Barel, M. Balbo, and R. Frade. 1995. Identification on melanoma cells of p39, a cysteine proteinase that cleaves C3, the third component of complement: amino-acid-sequence identities with procathepsin L. Biochem. J. 312: 961-969. (Pubitemid 26006012)
35. Ollert, M. W., R. Frade, A. Fiandino, M. Panneerselvam, E. C. Petrella, M. Barel, M. K. Pangburn, R. Bredehorst, and C. W. Vogel. 1990. C3-cleaving membrane proteinase. A new complement regulatory protein of human melanoma cells. J. Immunol. 144: 3862-3867.
36. Jean, D., M. Bar-Eli, S. Huang, K. Xie, F. Rodrigues-Lima, J. Hermann, and R. Frade. 1996. A cysteine proteinase, which cleaves human C3, the third component of complement, is involved in tumorigenicity and metastasis of human melanoma. Cancer Res. 56: 254-258. (Pubitemid 26026350)
37. Hong, Y. Q., and B. Ghebrehiwet. 1992. Effect of Pseudomonas aeruginosa elastase and alkaline protease on serum complement and isolated components C1q and C3. Clin. Immunol. Immunopathol. 62: 133-138.
38. Suter, S., U. B. Schaad, L. Roux, U. E. Nydegger, and F. A. Waldvogel. 1984. Granulocyte neutral proteases and Pseudomonas elastase as possible causes of airway damage in patients with cystic fibrosis. J. Infect. Dis. 149: 523-531. (Pubitemid 14139035)
39. Janssen, B. J., and P. Gros. 2007. Structural insights into the central complement component C3. Mol. Immunol. 44: 3-10.
40. Vogel, C. W., D. C. Fritzinger, B. E. Hew, M. Thorne, and H. Bammert. 2004. Recombinant cobra venom factor. Mol. Immunol. 41: 191-199.
41. Phipps, D., M. Menger, J. S. Chadwick, and W. P. Aston. 1987. A cobra venom factor (CVF)-induced C3 convertase activity in the hemolymph of Galleria mellonella. Dev. Comp. Immunol. 11: 37-46.
42. Sutterwala, F. S., L. A. Rosenthal, and D. M. Mosser. 1996. Cooperation between CR1 (CD35) and CR3 (CD 11b/CD18) in the binding of complement-opsonized particles. J. Leukocyte Biol. 59: 883-890.
43. Ehlers, M. R. 2000. CR3: a general purpose adhesion-recognition receptor essential for innate immunity. Microbes Infect. 2: 289-294. (Pubitemid 30167662)
44. Towbin, H., T. Staehelin, and J. Gordon. 1992. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Biotechnology 24: 145-149.